Study Venetoclax Effectiveness and Real-Life Treatment Management in Participants With Chronic Lymphocytic Leukemia

Venetoclax Resistance Landscape in Chronic Lymphocytic Leukemia

NCT05246345 ·Status: RECRUITING

A Study to Evaluate the Efficacy of Venetoclax Monotherapy in Relapsed/Refractory Participants With Chronic Lymphocytic Leukemia (CLL)

NCT02756611 ·Status: COMPLETED ·Phase: PHASE3

A Study of Clinical Outcomes in Chronic Lymphocytic Leukemia (CLL) Patients Treated With Venetoclax in Greece

NCT04159779 ·Status: ACTIVE_NOT_RECRUITING

Study to Describe the Management and the Use of Healthcare Resources in Patients With Chronic Lymphocytic Leukemia (CLL) Initiating Venetoclax in Routine Clinical Practice

NCT03310190 ·Status: COMPLETED

A Study of the Safety and Efficacy of Venetoclax for Participants With Chronic Lymphocytic Leukemia (CLL) Used in Routine Clinical Practice

NCT04178317 ·Status: COMPLETED

A Study of Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

NCT02966756 ·Status: RECRUITING ·Phase: PHASE2

An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial

NCT03844048 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study in Previously Untreated Chronic Lymphocytic Leukemia (CLL) Subjects, Excluding Those With the 17p Deletion, to Evaluate Debulking Regimens Prior to Initiating Venetoclax Combination Therapy

NCT03406156 ·Status: COMPLETED ·Phase: PHASE3

Venetoclax and Ibrutinib in Treating in Participants With Chronic Lymphocytic Leukemia and Ibrutinib Resistance Mutations

NCT03513562 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study of Venetoclax and Alvocidib in Patients With Relapsed/Refractory Acute Myeloid Leukemia

NCT03441555 ·Status: COMPLETED ·Phase: PHASE1

A Phase 2 Open-Label Study of the Efficacy and Safety of ABT-199 (GDC-0199) in Chronic Lymphocytic Leukemia (CLL) Subjects With Relapse or Refractory to B-Cell Receptor Signaling Pathway Inhibitor Therapy

NCT02141282 ·Status: COMPLETED ·Phase: PHASE2

Lymph Node Microenvironment Modifications in Patients With CLL Treated With Venetoclax-based Regimens

NCT04790045 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4

Early Clonal Dynamics During Venetoclax Treatment for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

NCT03986034 ·Status: RECRUITING ·Phase: PHASE2

A Study of Venetoclax in Combination With Obinutuzumab in Participants With Chronic Lymphocytic Leukemia

NCT01685892 ·Status: COMPLETED ·Phase: PHASE1

Venetoclax in Addition to Blinatumomab in Adult Patients With Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL)

NCT05182385 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia

NCT03826992 ·Status: RECRUITING ·Phase: PHASE1

A Study of Venetoclax in Combination With Low Dose Cytarabine Versus Low Dose Cytarabine Alone in Treatment Naive Patients With Acute Myeloid Leukemia Who Are Ineligible for Intensive Chemotherapy

NCT03069352 ·Status: COMPLETED ·Phase: PHASE3

Study of Venetoclax in Combination With Decitabine in Subjects With Acute Myeloid Leukemia

NCT03844815 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Study of the Relationship Between the Pharmacokinetics (PK) and Pharmacodynamics of Venetoclax in Patients With Acute Myeloblastic Leukemia

NCT07243483 ·Status: RECRUITING ·Phase: NA

A Study Evaluating the Impact of Venetoclax on the Quality of Life for Subjects With Relapsed (Your Cancer Has Come Back) or Refractory (no Response to Previous Cancer Treatments) Chronic Lymphocytic Leukemia (CLL) While Receiving Venetoclax Monotherapy (a Single Agent).

NCT02980731 ·Status: COMPLETED ·Phase: PHASE3

A Study Evaluating the Efficacy of Venetoclax Plus Ibrutinib in Participants With T-cell Prolymphocytic Leukemia

NCT03873493 ·Status: COMPLETED ·Phase: PHASE2

Venetoclax After TKI to Target Persisting Stem Cells in CML

NCT05701215 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Observational Study Relapsed or Refractory Chronic Lymphocytic Leukemia Venetoclax-based Regimens Outside Clinical Trials in Italy

NCT04282811 ·Status: RECRUITING

Venetoclax as Consolidation in CLL Patients Treated With BTK Inhibitor Monotherapy

NCT06958705 ·Status: RECRUITING ·Phase: PHASE2

Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax in Combination With Intravenous (IV) Obinutuzumab or Oral Ibrutinib in Adult Participants With Untreated Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

NCT05105841 ·Status: COMPLETED ·Phase: PHASE2